MK-0677 (Ibutamoren)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MK-0677 (Ibutamoren), covering 2012-01-06 to 2012-01-06. Get the full timeline:
Most recent: Clinical Trial Update: Growth Hormone Secretagogue MK-0677 Effect on IGF-1 Levels in ESRD Patients [NA]